BioArctic AB (OSTO:BIOA B) Total Liabilities : kr189 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is BioArctic AB Total Liabilities?

BioArctic AB's Total Liabilities for the quarter that ended in Mar. 2025 was kr189 Mil.

BioArctic AB's quarterly Total Liabilities increased from Sep. 2024 (kr174.44 Mil) to Dec. 2024 (kr216.74 Mil) but then declined from Dec. 2024 (kr216.74 Mil) to Mar. 2025 (kr189.15 Mil).

BioArctic AB's annual Total Liabilities increased from Dec. 2022 (kr72.07 Mil) to Dec. 2023 (kr139.50 Mil) and increased from Dec. 2023 (kr139.50 Mil) to Dec. 2024 (kr216.74 Mil).

BioArctic AB Total Liabilities Historical Data

The historical data trend for BioArctic AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioArctic AB Total Liabilities Chart

BioArctic AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

143.01

109.05

72.07

139.50

216.74

BioArctic AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															143.61	202.61	174.44	216.74	189.15

BioArctic AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

BioArctic AB's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	175.66	+	(41.079	+	7.105427357601E-15
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	217

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	1111.681	-	894.942
	=	217

BioArctic AB's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	151.472	+	(37.681	+	-1.4210854715202E-14
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	0)
	=	189

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	2123.117	-	1933.964
	=	189

BioArctic AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of BioArctic AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

BioArctic AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioArctic AB (OSTO:BIOA B) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BRCTF:USA BIOABs:UK 0RV2:UK B9A:Germany

Address

Warfvinges vag 35, Stockholm, SWE, SE-112 51

Website

https://www.bioarctic.se

BioArctic AB is a research-based biopharmaceutical company focusing on disease-modifying treatments and diagnostics for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, and ALS. In addition, the group is also focused on the development of a treatment with a combination of a biodegradable medical device and a drug substance for complete spinal cord injury. Geographically, it derives a majority of its revenue from Asia.

BioArctic AB Headlines

No Headlines